Table 2. Univariate and multivariate analysis of factors associated with survival of 315 HCC patients.
Overall survival | ||||||
---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
Variables | HR | 95%CI | P Value | HR | 95%CI | P Value |
Age(year) (≥60 vs <60) | 0.8958 | 0.6580–1.219 | 0.4871 | |||
Sex(female vs male) | 0.6165 | 0.4450-0.9740 | 0.0521 | |||
Serum AFP(ng/ml) (≥20 vs <20) | 1.167 | 0.8392-1.615 | 0.3671 | |||
HBV (no vs yes) | 0.8942 | 0.5668-1.391 | 0.6071 | |||
Cirrhosis (present vs absent) | 1.556 | 0.9808-2.204 | 0.0643 | |||
Tumor Number (single vs multiple) | 0.5553 | 0.4206-0.8662 | 0.0069 | 0.743 | 0.465-1.188 | 0.215 |
Tumor size(cm)(≥5 vs <5) | 1.987 | 1.454-2.640 | < 0.0001 | 1.751 | 1.207-2.540 | 0.003 |
Tumor differentiation (I-II vs III-IV) | 1.856 | 1.455-3.118 | 0.0001 | 1.432 | 1.012-2.025 | 0.043 |
TNM Stage (I-II vs III) | 1.662 | 1.215-2.207 | 0.0014 | 1.448 | 1.027-2.040 | 0.034 |
Barx2 expression (low vs high) | 2.049 | 1.412-2.596 | < 0.0001* | 1.659 | 1.148-2.398 | 0.007* |
Abbreviations: HR:hazard ratio; CI:confidence interval; AFP:alpha-fetoprotein
*P<0.05.